Hypoparathyroidism - management, information needs, and impact on daily living from the patients' perspective: results from a population-based survey.


Journal

Hormones (Athens, Greece)
ISSN: 2520-8721
Titre abrégé: Hormones (Athens)
Pays: Switzerland
ID NLM: 101142469

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 12 12 2022
accepted: 09 06 2023
medline: 25 8 2023
pubmed: 29 6 2023
entrez: 28 6 2023
Statut: ppublish

Résumé

Hypoparathyriodism (hypoPT) is a rare endocrine disorder. It is not known how hypoPT is managed in Germany or whether patients have unmet information needs or impairments in their daily living. HypoPT patients at a minimum of 6 months' post-diagnosis were invited to participate in an online survey through their treating physician or through patient organizations. An extensive questionnaire, which was developed and pilot-tested with hypoPT patients, was administered. A total of 264 patients with a mean age of 54.5 years (SD: 13.3), 85.2% female and 92% with postsurgical hypoPT, participated in the study. In total, 74% of the patients reported regular monitoring of serum calcium at least every 6 months, with lower control frequencies for phosphate (47%), magnesium (36%), creatinine (54%), and parathyroid hormone (50%), and 24-h urine calcium excretion (36%) on a yearly basis. Information on symptoms of hypo- and hypercalcemia was available in 72 and 45% of the patients. Information needs were related to the disease and its treatment as well as to nutrition, physical activities/sports, and support opportunities. Statistically significant differences for all information needs in association with symptom burden were observed. Hospitalization for hypocalcemia was reported by 32%, nutritional impairments (38%) or impact on work ability (52%) was available among patients with hypoPT. HypoPT patients experience impairments in daily living and report unmet information needs. Patient and physician education regarding hypoPT is one of the key concepts for improving the management of patients with hypoPT.

Identifiants

pubmed: 37380916
doi: 10.1007/s42000-023-00459-1
pii: 10.1007/s42000-023-00459-1
pmc: PMC10449945
doi:

Substances chimiques

Calcium SY7Q814VUP
Parathyroid Hormone 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

467-476

Informations de copyright

© 2023. The Author(s).

Références

J Endocrinol Invest. 2018 Oct;41(10):1221-1226
pubmed: 29516386
Eur J Endocrinol. 2021 Dec 1;186(2):R33-R63
pubmed: 34863037
Chirurg. 2018 Sep;89(9):699-709
pubmed: 29876616
Eur J Endocrinol. 2019 Jan 1;180(1):71-78
pubmed: 30407920
Eur J Endocrinol. 2019 Mar;180(3):P1-P22
pubmed: 30540559
Swiss Med Wkly. 2018 Jan 29;148:w14586
pubmed: 29376554
Eur J Endocrinol. 2015 Aug;173(2):G1-20
pubmed: 26160136
J Clin Endocrinol Metab. 2016 Aug;101(8):3045-53
pubmed: 27186861
Endocr Pract. 2014 May;20(5):427-46
pubmed: 24325999
Strahlenther Onkol. 2018 Jul;194(7):655-663
pubmed: 29532098
N Engl J Med. 2008 Jul 24;359(4):391-403
pubmed: 18650515
J Clin Endocrinol Metab. 2012 Dec;97(12):4507-14
pubmed: 23043192
Calcif Tissue Int. 2018 Aug;103(2):151-163
pubmed: 29511787
Eur J Intern Med. 2015 Jan;26(1):75-6
pubmed: 25498511
Exp Clin Endocrinol Diabetes. 2021 Dec;129(12):918-925
pubmed: 33694151
PLoS One. 2020 Mar 10;15(3):e0230130
pubmed: 32155210
J Med Econ. 2019 Nov;22(11):1141-1152
pubmed: 31124721
Eur J Endocrinol. 2019 Jun 1;181(3):P1-P19
pubmed: 31176307
JBMR Plus. 2020 Jun 05;4(7):e10368
pubmed: 32666019
PLoS One. 2020 May 8;15(5):e0232842
pubmed: 32384131
J Bone Miner Res. 2015 Sep;30(9):1738-44
pubmed: 25753591
J Clin Endocrinol Metab. 2015 Feb;100(2):407-16
pubmed: 25419882
J Bone Miner Res. 2013 Nov;28(11):2277-85
pubmed: 23661265
Clin Endocrinol (Oxf). 2020 Feb;92(2):159-168
pubmed: 31721256
Endocr Pract. 2014 Jul;20(7):671-9
pubmed: 24449664
J Endocrinol Invest. 2021 Jul;44(7):1437-1446
pubmed: 33128157
J Endocr Soc. 2020 Nov 28;5(2):bvaa181
pubmed: 33409439
Horm Metab Res. 2021 Oct;53(10):654-661
pubmed: 34517416
Endocrine. 2017 Oct;58(1):14-20
pubmed: 28822059
J Bone Miner Res. 2014 Nov;29(11):2504-10
pubmed: 24806578
J Intern Med. 2019 Apr;285(4):429-435
pubmed: 30485554
Thyroid. 2018 Jul;28(7):830-841
pubmed: 29848235
J Bone Miner Res. 2022 Dec;37(12):2566-2567
pubmed: 36375811
J Bone Miner Res. 2013 Dec;28(12):2570-6
pubmed: 23737456
J Clin Endocrinol Metab. 2016 Jun;101(6):2313-24
pubmed: 26938200
Hormones (Athens). 2021 Jun;20(2):323-332
pubmed: 33184762
Calcif Tissue Int. 2017 Mar;100(3):278-285
pubmed: 28012105
J Clin Endocrinol Metab. 2020 Dec 1;105(12):
pubmed: 32918085
J Clin Endocrinol Metab. 2016 Jun;101(6):2273-83
pubmed: 26943719
Horm Metab Res. 2016 Dec;48(12):806-813
pubmed: 27813050
Nurs Stand. 2015 Jul 1;29(44):50-7
pubmed: 26136035
Endocr Connect. 2020 Jul;9(7):627-636
pubmed: 32580149
Endocrine. 2021 May;72(2):553-561
pubmed: 33655415
Dtsch Med Wochenschr. 2019 Oct;144(21):e130-e137
pubmed: 31137038
Clin Endocrinol (Oxf). 2022 Sep;97(3):268-275
pubmed: 35192212
Arch Endocrinol Metab. 2018 Jun;62(3):319-324
pubmed: 29791658

Auteurs

Matthias Büttner (M)

Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center Mainz, Obere Zahlbacher Straße 69, 55131, Mainz, Germany. matbuett@uni-mainz.de.
University Cancer Centre, Mainz, Germany. matbuett@uni-mainz.de.

Dieter Krogh (D)

Netzwerk Hypopara im Bundesverband Schilddrüsenkrebs - Ohne Schilddrüse leben e.V., Berlin, Germany.

Dagmar Führer (D)

Department of Endocrinology, Diabetes and Metabolism and Division of Laboratory Research, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Carmina Teresa Fuß (CT)

Division of Endocrinology and Diabetes, Department of Medicine I, University Hospital, University of Würzburg, Würzburg, Germany.

Holger Sven Willenberg (HS)

Division of Endocrinology and Metabolism, Rostock University Medical Center, Rostock, Germany.

Markus Luster (M)

Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany.

Susanne Singer (S)

Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center Mainz, Obere Zahlbacher Straße 69, 55131, Mainz, Germany.
University Cancer Centre, Mainz, Germany.

Heide Siggelkow (H)

Clinic of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University of Göttingen, Göttingen, Germany.
MVZ Endokrinologikum Göttingen, Göttingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH